Nautilus Biotechnology, Inc. Profile Avatar - Palmy Investing

Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end…

Biotechnology
US, Seattle [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of NAUT's Analysis
CIK: 1808805 CUSIP: 63909J108 ISIN: US63909J1088 LEI: - UEI: -
Secondary Listings
NAUT has no secondary listings inside our databases.